Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

324
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
324
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

383
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
383
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

394
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
394
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

2.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.3K
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

394
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
394
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

430
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
430

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertrophic Cardiomyopathy and Sudden Cardiac Death: All in the Family?

JACC. Clinical electrophysiology·2026
Same author

Right Ventricular Dysfunction and Adverse Clinical Outcomes in Peripartum Cardiomyopathy: A Meta-Analysis.

JACC. Advances·2025
Same author

A case of a pacemaker follow-up: Too little, too late, part 2.

HeartRhythm case reports·2025
Same author

Landiolol for Treating Arrhythmias: A State-of-The-Art Review.

Cardiology in review·2024
Same author

Elucidation of Complex Atrial Tachycardia Activation in a Patient with Tetralogy of Fallot Using Omnipolar Mapping Technology: A Case Report.

The Journal of innovations in cardiac rhythm management·2024
Same author

Lead Extraction-Indications, Procedure, and Future Directions.

Cardiology in review·2023

Related Experiment Video

Updated: Dec 31, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.6K

Catecholaminergic Polymorphic Ventricular Tachycardia.

Chan W Kim1, Wilbert S Aronow, Tanya Dutta

  • 1From the Cardiology Division, Department of Medicine, NY Medical College and Westchester Medical Center, Valhalla, NY.

Cardiology in Review
|January 15, 2020
PubMed
Summary

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic heart condition causing dangerous arrhythmias. Current treatments include beta-blockers, with other therapies under investigation.

More Related Videos

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.2K
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

3.3K

Related Experiment Videos

Last Updated: Dec 31, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.6K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.2K
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

3.3K

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare, inherited arrhythmogenic disorder.
  • It is triggered by physical or emotional stress, primarily affecting children and young adults.
  • CPVT manifests as rapid ventricular tachycardia, potentially leading to syncope and sudden cardiac death.

Purpose of the Study:

  • To review the pathophysiology of CPVT, focusing on calcium ion handling.
  • To discuss genetic mutations associated with familial CPVT.
  • To outline current and potential therapeutic strategies for managing CPVT.

Main Methods:

  • Review of existing literature on CPVT.
  • Analysis of genetic mutations in cardiac ryanodine receptor and calsequestrin genes.
  • Discussion of therapeutic interventions.

Main Results:

  • CPVT results from impaired calcium handling in cardiac myocytes, often due to mutations in RYR2 or CASQ2 genes.
  • Catecholaminergic stimulation leads to excess diastolic calcium, causing delayed afterdepolarizations and arrhythmias.
  • Beta-blocker therapy is the primary treatment, supplemented by other interventions.

Conclusions:

  • Understanding the molecular basis of CPVT is crucial for developing effective treatments.
  • Current management involves beta-blockers, with ongoing research into novel therapies like verapamil and gene therapy.
  • Early diagnosis and comprehensive management are vital for improving outcomes in CPVT patients.